Several explanations have been suggested to explain the mechanisms induced by Activin A. In ESCC, one such proposal for Activin A contribution to tumor progression is through the induction of N-cadherin, with subsequent loss of E-cadherin, a feature that has been associated with increased tumor aggressiveness [24]. The gene discussed is CDH1; the disease is neoplasm.